Gallardo, Joisebel L.

HRN: 25-86-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2025
CEFUROXIME 1.5GM (VIAL)
08/26/2025
08/27/2025
IV
1.5 G
Q8 X 3 Doses
Sp 1 LTCS
Remove - Pending Acceptance
08/27/2025
CEFUROXIME 500MG (TAB)
08/27/2025
08/28/2025
ORAL
500mg
BID
Sp Pltcs
Remove - Pending Acceptance
08/28/2025
MUPIROCIN 2%, 15G (TUBE)
08/28/2025
08/28/2025
TOPICAL
1ml
OD
SP LTCS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: